-
1دورية أكاديمية
المؤلفون: Sierra‐Botero, Laura, Calonje, Michael, Robbins, Robert K., Rosser, Neil, Pierce, Naomi E., López‐Gallego, Cristina, Valencia‐Montoya, Wendy A.
المساهمون: State Corporation Commission
المصدر: Ecology and Evolution ; volume 13, issue 4 ; ISSN 2045-7758 2045-7758
-
2دورية أكاديمية
المؤلفون: Londoño, Julián, Pérez, Lucia, Moreno, Sergio, Chapman, Edgardo, Beatriz García, María, Celis, Ana María, Muñoz, María Angélica, Castillo, David, Sánchez, Jorge, Arevalo, Yaicith, Lozano, Ana, ALVIS-ZAKZUK, NELSON J., Muñoz, Cesar, Botero, Laura, Beltran, Catalina, García, Elizabeth
مصطلحات موضوعية: Atopic dermatitis, Dupilumab, Eczema, Biologic therapy
جغرافية الموضوع: Colombia
وصف الملف: 12 páginas; application/pdf
العلاقة: World Allergy Organization Journal; 1. Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis [Internet]. Nature Reviews Disease Primers. Nat Rev Dis Primers. 2018;4 [cited 2021 Aug 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/29930242Test/.; 2. Dennis RJ, Caraballo L, García E, et al. Prevalence of asthma and other allergic conditions in Colombia 2009-2010: a crosssectional study. BMC Pulm Med. 2012 Jul;12:17.; 3. Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy Eur J Allergy Clin Immunol. 2018;73(6):1284–1293.; 4. Silverberg JI, Gelfand JM, Margolis DJ, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol [Internet]. 2018 Sep 1;121(3):340–347. https://doiTest. org/10.1016/j.anai.2018.07.006 [cited 2021 Jun 21].; 5. Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the national eczema association. J Investig Dermatol. 2017;137:26–30. Elsevier B.V.; 6. Silverberg JI, Gelfand JM, Margolis DJ, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study [cited 2021 Aug 20] Ann Allergy Asthma Immunol [Internet]. 2018 Sep 1;121(3): 340–347. Available from: https://pubmed.ncbi.nlm.nih.govTest/ 30025911/.; 7. Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990– 2010: a systematic analysis for the Global Burden of Disease Study 2010 [cited 2021 Aug 20] Lancet [Internet]. 2012 Dec 15;380(9859):2197–2223. Available from: http://wwwTest. thelancet.com/article/S0140673612616894/fulltext.; 8. Beck LA, Thaçi D, Hamilton JD, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014;371(2):130–139.; 9. Simpson EL, Bieber T, Guttman-Yassky E, et al. Two Phase 3 Trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016 Dec;375(24):2335–2348.; 11. Faiz S, Giovannelli J, Podevin C, et al. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a reallife French multicenter adult cohort [cited 2021 Jan 4] J Am Acad Dermatol [Internet]. 2019 Jul 1;81(1):143–151. Available from: https://pubmed.ncbi.nlm.nih.gov/30825533Test/.; 12. Blauvelt A, de Bruin-Weller M, Gooderham M, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial [cited 2021 Nov 16] Lancet [Internet]. 2017 Jun 10;389(10086):2287–2303. Available from: http://www.thelancet.com/article/S0140673617311911Test/ fulltext.; 13. Caraballo L, Zakzuk J, Lee BW, et al. Particularities of Allergy in the Tropics [Internet]. BioMed Central Ltd. World Allergy Org J. 2016;9 [cited 2021 Jan 4]. Available from: https://pubmedTest. ncbi.nlm.nih.gov/27386040/; 14. Langan SM, Thomas KS, Williams HC. What is meant by a “flare” in atopic dermatitis?: a systematic review and proposal [cited 2022 Jun 9] Arch Dermatol [Internet]. 2006 Sep 1;142(9): 1190–1196. Available from: https://jamanetwork.com/journalsTest/ jamadermatology/fullarticle/407617.; 15. Blauvelt A, de Bruin-Weller M, Gooderham M, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet. 2017 Jun 10;389(10086):2287–2303.; 16. de Bruin-Weller M, Thaçi D, Smith CH, et al. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ) [cited 2020 Dec 17] Br J Dermatol [Internet]. 2018 May 1;178(5):1083–1101. Available from: https://pubmed.ncbi.nlm.nih.gov/29193016Test/.; 18. Caraballo L, Zakzuk J, Lee BW, et al. Particularities of allergy in the tropics [cited 2021 Aug 12] World Allergy Organ J [Internet]. 2016;9:20. Available from: http://www.ncbi.nlm.nihTest. gov/pubmed/27386040.; 19. Pérez-Herrera LC, Moreno-López S, Peñaranda D, García E, Chapman E, Peñaranda A. Frequency of self-reported allergies at a high-complexity referral hospital in Colombia, a tropical Latin American country [cited 2022 Jun 9] Allergol Immunopathol (Madr) [Internet]. 2021 Sep 1;49(5):100–105. Available from: https://www.all-imm.com/index.php/aeiTest/ article/view/449/627.; 20. Nettis E, Patella V, Lombardo C, et al. Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis [cited 2021 Nov 16] Allergy [Internet]. 2020 Oct 1;75(10):2653–2661. Available from: https://pubmed.ncbiTest. nlm.nih.gov/32424957/.; 21. Ribero S, Giura MT, Viola R, et al. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience [cited 2021 Nov 16] J Eur Acad Dermatol Venereol [Internet]. 2020 Aug 1;34(8):e380–e383. Available from: https://pubmed.ncbi.nlmTest. nih.gov/31960496/.; 22. Quint T, Brunner PM, Sinz C, et al. Dupilumab for the treatment of atopic dermatitis in an Austrian cohort-real-life data shows Rosacea-like Folliculitis [cited 2021 Nov 16] J Clin Med [Internet]. 2020 Apr 1;9(4). Available from: https://pubmedTest. ncbi.nlm.nih.gov/32344789/.; 23. Armario-Hita JC, Pereyra-Rodriguez J, Silvestre JF, et al. Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series [cited 2021 Nov 16] Br J Dermatol [Internet]. 2019 Nov 1;181(5):1072–1074. Available from: https://pubmedTest. ncbi.nlm.nih.gov/31021399/.; 24. Ruiz-Villaverde R, Dominguez-Cruz J, Armario-Hita JC, et al. Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series [cited 2021 Nov 16]. Dermatol Ther [Internet]. 2019;32(4):e12931. Available from: https://pubmed.ncbi.nlm.nih.gov/30980485Test/.; 26. Abraham S, Haufe E, Harder I, et al. Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany [Internet] [cited 2021 Sep 18] British Journal of Dermatology. Br J Dermatol. 2020;183:382–384. Available from: https://pubmed.ncbi.nlmTest. nih.gov/32068242/.; 27. Kreeshan FC, Al-Janabi A, Warren RB, Hunter HJA. Real-World experience and laboratory monitoring of dupilumab in patients with moderate to severe atopic dermatitis in a tertiary centre [cited 2021 Nov 16] Dermatol Ther (Heidelb) [Internet]. 2021 Feb 1;11(1):149–160. Available from: https://pubmedTest. ncbi.nlm.nih.gov/33315229/.; 28. Fargnoli MC, Esposito M, Ferrucci S, et al. A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis. J Dermatolog Treat [Internet]. 2022 Mar;33(2):1146–1149 [cited 2021 Nov 16]; Available from: https://pubmed.ncbi.nlm.nihTest. gov/32436765/ [cited 2021 Nov 16]; Available from:.; 29. Sanchez J, Cherrez-Ojeda I, Galvan C, et al. The unmet needs in atopic dermatitis control in Latin America: a multidisciplinary expert perspective [cited 2021 Sep 18] Dermatology Ther 2021 [Internet]; 2021 Aug 27:1–20. Available from: https://linkTest. springer.com/article/10.1007/s13555-021-00595-9.; 30. Akinlade B, Guttman-Yassky E, de Bruin-Weller M, et al. Conjunctivitis in dupilumab clinical trials [cited 2021 Nov 16] Br J Dermatol [Internet]. 2019 Sep 1;181(3):459–473. Available from: https://pubmed.ncbi.nlm.nih.gov/30851191Test/.; 31. Wollenberg A, Ariens L, Thurau S, van Luijk C, Seegräber M, de Bruin-Weller M. Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment [cited 2021 Nov 16] J allergy Clin Immunol Pract [Internet]. 2018 Sep 1;6(5):1778–1780.e1. Available from: https://pubmed.ncbi.nlm.nih.gov/29432961Test/.; 32. Ivert LU, Wahlgren CF, Ivert L, Lundqvist M, Bradley M. Eye complications during dupilumab treatment for severe atopic dermatitis [cited 2021 Nov 16] Acta Derm Venereol [Internet]. 2019 Apr 1;99(4):375–378. Available from: https://pubmedTest. ncbi.nlm.nih.gov/30653240/.; 33. de Wijs LEM, Nguyen NT, Kunkeler ACM, Nijsten T, Damman J, Hijnen DJ. Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series [cited 2021 Nov 16] Br J Dermatol [Internet]. 2020 Oct 1;183(4):745–749. Available from: https://pubmed.ncbi.nlm.nih.gov/31749159Test/.; 34. Barnes AC, Blandford AD, Perry JD. Cicatricial ectropion in a patient treated with dupilumab [cited 2021 Nov 16] Am J Ophthalmol case reports [Internet]. 2017 Sep 1;7:120–122. Available from: https://pubmed.ncbi.nlm.nih.gov/29260094Test/.; 35. Maudinet A, Law-Koune S, Duretz C, Lasek A, Modiano P, Tran THC. Ocular surface diseases Induced by dupilumab in severe atopic dermatitis [cited 2021 Nov 16] Ophthalmol Ther [Internet]. 2019 Sep 1;8(3):485–490. Available from: https:// pubmed.ncbi.nlm.nih.gov/31230264/.; 36. Halling AS, Loft N, Silverberg JI, Guttman-Yassky E, Thyssen JP. Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis [cited 2021 Nov 16] J Am Acad Dermatol [Internet]. 2021 Jan 1;84(1):139–147. Available from: https://pubmed.ncbi.nlm.nih.gov/32822798Test/.; 37. Ferrucci S, Angileri L, Tavecchio S, et al. Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease. J Dermatol Treat. 2022 Aug;33(5):2587–2592.; 38. Máspero J, Angles MV, Ardusso L, et al. Análisis de una serie de casos de pacientes adultos con dermatitis atópica severa tratados con dupilumab en Argentina [cited 2023 Jan 14] Rev Fac Cien Med Univ Nac Cordoba [Internet]. 2020 Jun 9;77(2): 94–99. Available from: https://pubmed.ncbi.nlm.nih.govTest/ 32558511/.; 39. Vergara C, Caraballo L, Mercado D, et al. African ancestry is associated with risk of asthma and high total serum IgE in a population from the Caribbean Coast of Colombia [cited 2022 May 2] Hum Genet [Internet]. 2009;125(5–6):565–579. Available from: https://pubmed.ncbi.nlm.nih.gov/19290544Test/.; 40. Touhouche AT, Cassagne M, Bérard E, et al. Incidence and risk factors for dupilumab associated ocular adverse events: a reallife prospective study. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):172–179.; 12; 16; Julián Londoño, Lucia Perez, Sergio Moreno, Edgardo Chapman, María Beatriz Garcia, Ana María Celis, María Angélica Muñoz, David Castillo, Jorge Sánchez, Yaicith Arevalo, Ana Lozano, Nelson J. Alvis-Zakzuk, Cesar Muñoz, Laura Botero, Catalina Beltran, Elizabeth García, Effectiveness and safety of dupilumab in adults with moderate and severe atopic dermatitis in Colombia: Real-life experience, World Allergy Organization Journal, Volume 16, Issue 4, 2023, 100763, ISSN 1939-4551, https://doi.org/10.1016/j.waojou.2023.100763Test; https://hdl.handle.net/11323/10454Test; Corporación Universidad de la Costa; REDICUC - Repositorio CUC; https://repositorio.cuc.edu.coTest/
الإتاحة: https://doi.org/10.1016/j.waojou.2023.100763Test
https://doi.org/10.1016/j.anai.2018.07.006Test
https://hdl.handle.net/11323/10454Test
https://repositorio.cuc.edu.coTest/ -
3دورية أكاديمية
المؤلفون: Segovia, Javier Mauricio, Cantor, Erick Andrés, Vargas, Henry Alexander, Sanabria, Daniel Eduardo, Murillo, John Alejandro, Gomez Botero, Laura
المصدر: International Journal of Gynecology & Obstetrics ; ISSN 0020-7292 1879-3479
-
4دورية أكاديمية
المؤلفون: Ali, Abraham, García, Elizabeth, Torres-Duque, Carlos A, Rey, Diana, Botero, Laura, Saenz, Stid, Avila, Maria Paula, Mazo, Elizabeth, Londoño, Sergio
المساهمون: Sanofi Colombia
المصدر: Expert Review of Pharmacoeconomics & Outcomes Research ; volume 24, issue 3, page 361-374 ; ISSN 1473-7167 1744-8379
-
5دورية أكاديمية
المؤلفون: Botero, Laura
المساهمون: Universidad EAFIT
المصدر: Revista Universidad EAFIT, Vol. 50, Núm. 165 (2015)
جغرافية الموضوع: Medellín de: Lat: 06 15 00 N degrees minutes Lat: 6.2500 decimal degrees Long: 075 36 00 W degrees minutes Long: -75.6000 decimal degrees
وصف الملف: application/pdf; text/html
-
6دورية أكاديمية
المؤلفون: Botero, Laura
المساهمون: Universidad EAFIT
المصدر: Revista Universidad EAFIT, Vol. 50, Núm. 165 (2015)
جغرافية الموضوع: Medellín de: Lat: 06 15 00 N degrees minutes Lat: 6.2500 decimal degrees Long: 075 36 00 W degrees minutes Long: -75.6000 decimal degrees
وصف الملف: application/pdf; text/html
-
7دورية أكاديمية
المصدر: Iatreia; Vol. 36 No. 4 (2023) ; Iatreia; Vol. 36 Núm. 4 (2023) ; 2011-7965 ; 0121-0793
مصطلحات موضوعية: Elderly, Nutritional Status, Multimorbidity, Polypharmacy, Health sciences, nutrition, dietetics, Public health, Adulto mayor, Estado nutricional, Multimorbilidad, Polifarmacia, Ciencias de la salud, Nutrición, dietética, Salud pública
وصف الملف: application/pdf
-
8دورية أكاديمية
المؤلفون: Molina Botero, Laura, Becerra Uribe, Santiago
المصدر: Revista Sítio Novo; 2022: Edição especial; 113-125 ; 2594-7036 ; 10.47236/2594-7036.2022.v7.i0
مصطلحات موضوعية: Perfil de velocidades de viento. Simulaciones CFD. Ventilación natural en torres de vivienda
وصف الملف: application/pdf
العلاقة: https://sitionovo.ifto.edu.br/index.php/sitionovo/article/view/1196/360Test; https://sitionovo.ifto.edu.br/index.php/sitionovo/article/downloadSuppFile/1196/1000Test; https://sitionovo.ifto.edu.br/index.php/sitionovo/article/downloadSuppFile/1196/1003Test; BAKER, W., DEVIN, A., LOMBARDO, F., MOORJANI, R., RAY, S., YOUNG, B. Influence of vented floors on the across-wind response of tall buildings. Journal of Wind Engineering and Industrial Aerodynamics, Vol. 209, 104480. 2021.; DAEMEI, A. O. Study on Vernacular Architecture Patterns to Improve Natural Ventilation Estimating in Humid Subtropical Climate. Civil Engineering Journal, Vol. (4) No. 9, 2097-2110. 2018.; DANIELS, K. The technology of ecological building: basic principles and measures, examples and ideas: Alemania Birkhauser. 1997.; GARCÍA, A. A. Evaluación de la incursión del viento y la iluminación a través de los vanos en aulas de jardines infantiles en Medellín, Colombia. Arquitectura y Urbanismo, Vol. (XXXVII). 2016.; GARCÍA, A. A. Evaluación integrada de iluminación natural, ventilación y ruido en tres aulas infantiles de Medellín, Colombia. MACDES 2018. Quinto Congreso Internacional en Medio Ambiente Construido y Desarrollo Sustentable. Habana, Cuba. 2018.; INSTITUTO COLOMBIANO DE NORMAS TÉCNICAS Y CERTIFICACIÓN (ICONTEC). NTC 5138: Ventilación para una calidad de aire aceptable en espacios interiores. (s.f).; INSTITUTO DE HIDROLOGÍA, METEOROLOGÍA Y ESTUDIOS AMBIENTALES. Atlas de Viento de Colombia. Recuperado en noviembre de 2020, de: http://atlas.ideam.gov.co/visorAtlasVientos.htmlTest; JÓŹWIAK, R., KACPRZYK, J, ŻURAŃSKI, J.A. Influence of wind direction on natural ventilation of apartment buildings. Journal of Wind Engineering and Industrial Aerodynamics, Vol 60. 167-176. 1996.; MEISS, A.; PADILLA-MARCOS, M. A.; FEIJÓ-MUÑOZ, J. Methodology Applied to the Evaluation of Natural Ventilation in Residential Building Retrofits: A Case Study. Energies, 10, 456. 2017.; QINGSHAN, Y., TAMURA, Y., YOSHIDA, A., XU, X. Characteristics of pedestrian-level wind around super-tall buildings with various configurations. Journal of Wind Engineering and Industrial Aerodynamics, Vol. 166. 61-73. 2017.; RINCÓN, J. L. (2019). Incidencia del porcentaje de abertura de las ventanas en la ventilación natural y el ruido de fondo en tres tipos diferentes de aulas de básica primaria en Medellín, Colombia. Recuperado de http://bibliotecadigital.usb.edu.coTest.; WEERASURIYA, A. U. Computational Fluid Dynamic (CFD) Simulation of Flow around Tall Buildings. ENGINEER, Vol. (XXXXVI), No. 03. 43-54. 2013.; YARKE, E. Ventilación natural de edificios Fundamentos y Métodos de Cálculo para aplicación de Ingenieros y Arquitectos. Buenos Aires, Argentina: Nobuko. 2005.; https://sitionovo.ifto.edu.br/index.php/sitionovo/article/view/1196Test
الإتاحة: https://doi.org/10.47236/2594-7036.2022.v7.i0.113-125pTest
https://doi.org/10.47236/2594-7036.2022.v7.i0Test
https://sitionovo.ifto.edu.br/index.php/sitionovo/article/view/1196Test -
9دورية أكاديمية
المصدر: Multiple Sclerosis and Related Disorders ; volume 61, page 103780 ; ISSN 2211-0348
مصطلحات موضوعية: Neurology (clinical), Neurology, General Medicine
الإتاحة: https://doi.org/10.1016/j.msard.2022.103780Test
https://api.elsevier.com/content/article/PII:S2211034822002954?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2211034822002954?httpAccept=text/plainTest -
10تسجيل فيديو
المؤلفون: Medina Godoy, Esteban, Isaza, Mario Esteban, Rey Torres, María José, Suárez, Daniela, Meza, Roberto, Hamann, Daniel, Martínez, Andrés, Botero, Laura, Puentes, Valery
المصدر: Universidad de La Sabana ; Intellectum Repositorio Universidad de La Sabana
مصطلحات موضوعية: Deportes al aire libre
العلاقة: https://www.youtube.com/watch?v=WuIPYvtp1yU&feature=youtu.beTest; http://hdl.handle.net/10818/38036Test
النص الكامل